IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines
Clinical trial NCT00430963 · COMPLETED
Trial details
- NCT number
- NCT00430963
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2007-04-01
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.